SIGRAL Suspension 200ml

Ulcer/Reflux/Flatulence Rx required
OUT OF STOCK

Best Price* ₹ 133.06 MRP ₹ 147.84
(Inclusive of all taxes) * Mkt: Signova Pharma Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout



INTRODUCTION

SIGRAL SUSPENSION contains Sucralfate, which belongs to the group of medicines called Anti-ulcer agents. It is used for the short-term (up to 8 weeks) treatment of active duodenal ulcers (part of the small intestine), prophylaxis of gastrointestinal haemorrhage due to stress ulceration in critically ill patients, gastric and benign ulcers.

SIGRAL SUSPENSION should be used with caution in patients with chronic renal failure, dialysis patients and diabetes. SIGRAL SUSPENSION should be used with caution in pregnant and breastfeeding women. The safety and effectiveness of SIGRAL SUSPENSION for use in children have not been established.

SIGRAL SUSPENSION should be used with caution in elderly patients above 65 years of age. The most common side effect of taking SIGRAL SUSPENSION is constipation. Consult your doctor if any of your symptoms get worse or persist.

USES OF SIGRAL SUSPENSION

  • Treatment of active duodenal ulcer, benign and gastric ulcers
  • Prophylaxis management of gastrointestinal haemorrhage

HOW SIGRAL SUSPENSION WORKS

SIGRAL SUSPENSION works by forming a protective layer around the ulcer saving it from the further attack of acid, pepsin or bile. It increases growth factor production, promoting tissue growth, regeneration, thereby facilitating repair.

DIRECTIONS FOR USE

Take SIGRAL SUSPENSION as advised by your physician. Shake well before each use. Take SIGRAL SUSPENSIONon an empty stomach at least 1 hour before or 2 hours after a meal for best results. Your doctor will determine the correct dose and duration for you based on your age, body weight and disease condition.

SIDE EFFECTS OF SIGRAL SUSPENSION

COMMON

  • constipation

HOW TO MANAGE SIDE EFFECTS

Constipation:

Consume fiber-rich foods such as fresh fruits, vegetables and cereals. Consume lots of water and exercise more regularly. Contact your doctor if your symptom doesn’t improve.

WARNING & PRECAUTIONS

PREGNANCY

SIGRAL SUSPENSION should be used with caution in pregnant women or women planning to have a baby. It will be given to you by the doctor only if clearly needed. Contact your doctor before taking SIGRAL SUSPENSION.

BREASTFEEDING

SIGRAL SUSPENSION should be used with caution in breastfeeding women as it is not known whether it passes into breast milk. Contact your doctor before taking SIGRAL SUSPENSION.

DRIVING AND USING MACHINES

Do not drive or operate any machines if you feel any unusual effects after taking SIGRAL SUSPENSION.

KIDNEY

SIGRAL SUSPENSION should be used with caution in patients with chronic kidney failure and patients undergoing dialysis. Contact your doctor before taking SIGRAL SUSPENSION.

ALLERGY

Do not take SIGRAL SUSPENSION if you are allergic to Sucralfate or any of the other ingredients in this medicine.

OTHERS

Before taking SIGRAL SUSPENSION, inform your doctor if you have:

  • diabetes

Use in paediatrics:

The safety and effectiveness of SIGRAL SUSPENSION for use in children have not been established. Contact your doctor before taking SIGRAL SUSPENSION.

Use in geriatrics:

SIGRAL SUSPENSION should be used with caution in elderly patients aged 65 years or above, especially with decreased liver, kidney and cardiac function or other diseases. Contact your doctor before taking SIGRAL SUSPENSION.

INTERACTIONS

A. Drug-Drug interactions:

Before taking SIGRAL SUSPENSION, inform your doctor if you are taking any of the following medicine:

  • ranitidine, cimetidine (medicine used to treat stomach acidity and peptic ulcer)
  • digoxin (a medicine used to treat heart failure), quinidine (a medicine used to treat irregular heart rate)
  • antibiotics like fluoroquinolone, ciprofloxacin, norfloxacin, ofloxacin, ketoconazole and tetracycline (medicines used to treat bacterial infections)
  • l-thyroxine (a medicine used to treat low thyroid hormone)
  • phenytoin (a medicine used to treat epilepsy)
  • theophylline (medicine used to treat wheezing, shortness of breath and chest tightness)
  • warfarin (to prevent blood clots)

Overdosage:

If you or anyone else accidentally take too much of SIGRAL SUSPENSION, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage are nausea, vomiting, indigestion and abdominal pain.

SYNOPSIS

Drug :   Sucralfate
Pharmacological Category :   Anti-ulcer agents
Therapeutic Indication :   Stomach Ulcer
Dosage Forms :   Tablet, Diskettes, Enema,Cream, Gel, Oral Gel, Oral Solution, Oral Suspension, Suspension, Syrup

MORE INFORMATION

  • Keep SIGRAL SUSPENSION out of reach from children
  • Store SIGRAL SUSPENSION below 30°C

FAQs ABOUT SIGRAL SUSPENSION

What is SIGRAL SUSPENSION used for?

SIGRAL SUSPENSION is used for the short-term (up to 8 weeks) treatment of active duodenal ulcer (part of the small intestine), prophylaxis of gastrointestinal haemorrhage due to stress ulceration in critically ill patients, gastric and benign ulcers.

Is SIGRAL SUSPENSION safe in pregnancy?

SIGRAL SUSPENSION should be used with caution in pregnant women or women planning to have a baby. It will be given to you by the doctor only if clearly needed. Contact your doctor before taking SIGRAL SUSPENSION.

Can SIGRAL SUSPENSION be used in elderly patients?

SIGRAL SUSPENSION should be used with caution in elderly patients aged 65 years or above, especially with decreased liver, kidney and cardiac function or other diseases. Contact your doctor before taking SIGRAL SUSPENSION.

How SIGRAL SUSPENSION work?

SIGRAL SUSPENSION works by forming a protective layer around the ulcer, saving it from further attack by acid, pepsin or bile. It increases growth factor production, promoting tissue growth, regeneration, thereby facilitating repair.

Can SIGRAL SUSPENSION be used in patients with kidney problems?

SIGRAL SUSPENSION should be used with caution in patients with chronic kidney failure and patients undergoing dialysis. Contact your doctor for more information before taking it.

REFERENCES

1. KD Tripathi. Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease. Essentials of Medical Pharmacology. Seventh Edition, 2013. Page - 656.

2. Wallace JL, Sharkey KA. Pharmacotherapy of Gastric Acidity, Peptic Ulcers and Gastroesophageal Reflux Disease. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 1315.

3. Kudaravalli P, John S. Sucralfate. StatPearls [Internet]. NIH National Library of Medicine. National Center for Biotechnology Information. [Revised in February 2022] [Accessed on 18th October 2022] https://www.ncbi.nlm.nih.gov/books/NBK551527/

4. R N Brogden, R C Heel, T M Speight, G S Avery. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. NIH National Library of Medicine. National Center for Biotechnology Information. Pubmed.gov 1984. [Accessed on 18th October 2022] https://pubmed.ncbi.nlm.nih.gov/6368184/#:~:text=Sucralfate%20is%20a%20basic%20aluminium%20salt%20of%20sulphated,effects%20of%20pepsin%2C%20acid%20and%20possibly%20bile%20salts.

5. Aptalis Pharma US, Inc. U.S. Food & Drug Administration. [Revised in March 2013] [Accessed on 18th October 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf

6. Sucralfate. Pharmaceutical Associates, Inc. [Revised in January 2022] [Accessed on 18th October 2022] https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=fa6e4661-1bee-4a64-b982-9d44dbdb8498&type=display

7. Sucralfate. Amneal Pharmaceuticals LLC. [Revised in February 2021] [Accessed on 18th October 2022] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4350b771-76a9-4e00-93f0-a18c71288f83

8. Sucralfate. Aptalis Pharma Canada Inc. [Revised in September 2013] [Accessed on 18th October 2022] https://allerganwebcdnprod.azureedge.net/allergancanadaspecialty/allergancanadaspecialty/media/actavis-canada-specialty/en/products/pms/sulcrate_pm_12sep2013_eng.pdf

9. Zuventus Healthcare Ltd. Ancool SF (Sucralfate 500mg). [Accessed on 18th October 2022] http://www.zuventus.co.in/patient_wise_products_selected.aspx?Medi_Id=256

10. Fourrts India Laboratories Pvt Ltd. Sucralfate. [Accessed on 18th October 2022] https://www.fourrts.com/sucrafil/

11. Wellona Pharma. Sucralfate. [Accessed on 18th October 2022] https://wellonapharma.com/product/finished/sucralfate-suspension

USEFUL DIAGNOSTIC TESTS

  • Kidney function test

PRODUCT DETAILS

    Net Qty
    1 N
    Item Weight
    220 g
    Ingredient
    SUCRALFATE 1000 mg
    Hsn Code
    30049039
ALTERNATE BRANDS View All
SPARACID DS Suspension 100ml
Prescription Ulcer/Reflux/Flatulence Rx required
Rs.86.83
SUCRAZEST Suspension 100ml
Prescription Ulcer/Reflux/Flatulence
Rs.87.00
SUCRAWIN 1000 Suspension 100ml
Prescription Ulcer/Reflux/Flatulence Rx required
Rs.87.00
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2023. All Rights Reserved.